Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1211330.RA523piO9zZM-SWFNnNQEc2u4d6esRM8_Q9gPltyjWNIQ130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1211330.RA523piO9zZM-SWFNnNQEc2u4d6esRM8_Q9gPltyjWNIQ130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1211330.RA523piO9zZM-SWFNnNQEc2u4d6esRM8_Q9gPltyjWNIQ130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1211330.RA523piO9zZM-SWFNnNQEc2u4d6esRM8_Q9gPltyjWNIQ130_provenance.
- NP1211330.RA523piO9zZM-SWFNnNQEc2u4d6esRM8_Q9gPltyjWNIQ130_assertion description "[Here, we show that treatment of NRAS-mutant melanoma cell lines with the MEK inhibitors AZD6244 or trametinib resulted in a rebound activation of phospho-ERK (pERK).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1211330.RA523piO9zZM-SWFNnNQEc2u4d6esRM8_Q9gPltyjWNIQ130_provenance.
- NP1211330.RA523piO9zZM-SWFNnNQEc2u4d6esRM8_Q9gPltyjWNIQ130_assertion evidence source_evidence_literature NP1211330.RA523piO9zZM-SWFNnNQEc2u4d6esRM8_Q9gPltyjWNIQ130_provenance.
- NP1211330.RA523piO9zZM-SWFNnNQEc2u4d6esRM8_Q9gPltyjWNIQ130_assertion SIO_000772 25130256 NP1211330.RA523piO9zZM-SWFNnNQEc2u4d6esRM8_Q9gPltyjWNIQ130_provenance.
- NP1211330.RA523piO9zZM-SWFNnNQEc2u4d6esRM8_Q9gPltyjWNIQ130_assertion wasDerivedFrom befree-2016 NP1211330.RA523piO9zZM-SWFNnNQEc2u4d6esRM8_Q9gPltyjWNIQ130_provenance.
- NP1211330.RA523piO9zZM-SWFNnNQEc2u4d6esRM8_Q9gPltyjWNIQ130_assertion wasGeneratedBy ECO_0000203 NP1211330.RA523piO9zZM-SWFNnNQEc2u4d6esRM8_Q9gPltyjWNIQ130_provenance.
- befree-2016 importedOn "2016-02-19" NP1211330.RA523piO9zZM-SWFNnNQEc2u4d6esRM8_Q9gPltyjWNIQ130_provenance.